UroGen Pharma Ltd. Quarterly Common Stock, Shares, Issued from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
UroGen Pharma Ltd. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2016 to Q3 2024.
  • UroGen Pharma Ltd. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 42.2M shares, a 36.7% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 42.2M +11.3M +36.7% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 41.2M +17.7M +75.2% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 36.1M +12.7M +54.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 32.5M +9.36M +40.5% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 30.9M +7.84M +34.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 23.5M +771K +3.39% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 23.4M +758K +3.34% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 23.1M +667K +2.97% Dec 31, 2022 10-K 2024-03-14
Q3 2022 23M +606K +2.71% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 22.7M +373K +1.67% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 22.7M +402K +1.8% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 22.5M +295K +1.33% Dec 31, 2021 10-K 2023-03-24
Q3 2021 22.4M +333K +1.51% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 22.4M +353K +1.61% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 22.3M +1.07M +5.03% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 22.2M +1.14M +5.43% Dec 31, 2020 10-K 2022-03-21
Q3 2020 22.1M +1.13M +5.38% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 22M +1.15M +5.52% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 21.2M +455K +2.19% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 21M +4.81M +29.7% Dec 31, 2019 10-K 2021-03-18
Q3 2019 20.9M +4.84M +30.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 20.8M +5M +31.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 20.8M +5.28M +34.2% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 16.2M +2.46M +17.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 16.1M Sep 30, 2018 6-K 2018-11-13
Q2 2018 15.9M Jun 30, 2018 6-K 2018-08-14
Q1 2018 15.5M Mar 31, 2018 6-K 2018-05-15
Q4 2017 13.8M +11.4M +496% Dec 31, 2017 10-K 2019-02-28
Q4 2016 2.31M Dec 31, 2016 20-F 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.